Press Release IlluminaIllumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme’s Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually | Newswise NewswiseIllumina invests in MyOme to advance AI-driven genomic health models By Investing.com Investing.com IndiaIllumina (NASDAQ: ILMN) invests in MyOme to launch AI-driven WGS trial in 2026 Stock Titan
